Effectiveness of a novel rat model of off-target PLA2R1 knockout to renal impairment
Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved..
Phospholipase A2 receptor 1 (PLA2R1) plays a crucial role in various diseases, including membranous nephropathy. However, the precise implications of PLA2R1 deficiency remain poorly understood. In this study, we created PLA2R1 knockout rats to explore potential consequences resulting from the loss of the PLA2R1 gene. Unexpectedly, our PLA2R1 knockout rats exhibited symptoms resembling those of chronic kidney disease after an 8-week observation period. Notably, several rats developed persistent proteinuria, a hallmark of renal dysfunction. Immunohistochemical and immunofluorescence analyses revealed insignificant glomerular fibrosis, reduced podocyte count, and augmented glomerular expression of complement C3 (C3) compared to immunoglobin A (IgA) and immunoglobin G(IgG) in the rat model. These findings suggest that the loss of PLA2R1 may contribute to the pathogenesis of membranous nephropathy and related conditions. Our knockout rat model provides a valuable tool for investigating the underlying pathology of PLA2R1-associated diseases, and may facilitate the development of targeted therapies for membranous nephropathy and other related disorders.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:116 |
|---|---|
| Enthalten in: |
Genomics - 116(2024), 2 vom: 21. März, Seite 110796 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Huang, Bo [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Autoantibodies |
|---|
| Anmerkungen: |
Date Completed 22.03.2024 Date Revised 25.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ygeno.2024.110796 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367282429 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367282429 | ||
| 003 | DE-627 | ||
| 005 | 20240325234648.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240119s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ygeno.2024.110796 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1346.xml |
| 035 | |a (DE-627)NLM367282429 | ||
| 035 | |a (NLM)38237745 | ||
| 035 | |a (PII)S0888-7543(24)00017-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Huang, Bo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Effectiveness of a novel rat model of off-target PLA2R1 knockout to renal impairment |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.03.2024 | ||
| 500 | |a Date Revised 25.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a Phospholipase A2 receptor 1 (PLA2R1) plays a crucial role in various diseases, including membranous nephropathy. However, the precise implications of PLA2R1 deficiency remain poorly understood. In this study, we created PLA2R1 knockout rats to explore potential consequences resulting from the loss of the PLA2R1 gene. Unexpectedly, our PLA2R1 knockout rats exhibited symptoms resembling those of chronic kidney disease after an 8-week observation period. Notably, several rats developed persistent proteinuria, a hallmark of renal dysfunction. Immunohistochemical and immunofluorescence analyses revealed insignificant glomerular fibrosis, reduced podocyte count, and augmented glomerular expression of complement C3 (C3) compared to immunoglobin A (IgA) and immunoglobin G(IgG) in the rat model. These findings suggest that the loss of PLA2R1 may contribute to the pathogenesis of membranous nephropathy and related conditions. Our knockout rat model provides a valuable tool for investigating the underlying pathology of PLA2R1-associated diseases, and may facilitate the development of targeted therapies for membranous nephropathy and other related disorders | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Complement deposition | |
| 650 | 4 | |a Membranous nephropathy | |
| 650 | 4 | |a Nephrotic syndrome | |
| 650 | 4 | |a Phospholipase A2 receptor 1 (PLA2R1) | |
| 650 | 4 | |a Podocyte | |
| 650 | 4 | |a Rat model | |
| 650 | 7 | |a Autoantibodies |2 NLM | |
| 650 | 7 | |a Receptors, Phospholipase A2 |2 NLM | |
| 700 | 1 | |a Zhang, Zitong |e verfasserin |4 aut | |
| 700 | 1 | |a Sui, Wendong |e verfasserin |4 aut | |
| 700 | 1 | |a Zhao, Lu |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Yinyin |e verfasserin |4 aut | |
| 700 | 1 | |a Feng, Li |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, Daihe |e verfasserin |4 aut | |
| 700 | 1 | |a Zhou, Yun |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Genomics |d 1990 |g 116(2024), 2 vom: 21. März, Seite 110796 |w (DE-627)NLM012628867 |x 1089-8646 |7 nnns |
| 773 | 1 | 8 | |g volume:116 |g year:2024 |g number:2 |g day:21 |g month:03 |g pages:110796 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ygeno.2024.110796 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 116 |j 2024 |e 2 |b 21 |c 03 |h 110796 | ||